- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03264963
Upper Airway Training for Treatment of Snoring
November 6, 2017 updated by: University of Minnesota
Upper Airway Training for Treatment of Snoring Using Smartphone Application
The objective of this study is to reduce the incidence or intensity of snoring in a patient population of known simple snorers without sleep apnea using smartphone based application which allows participants to play voice controlled games using various articulations resulting in tongue base movements.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Fluent in English.
- Age is between 20 and 65.
- BMI less than 32
- Less than 5% variance in weight since sleep study.
Snoring without health risk related to sleep apnea and not currently receiving treatment.
- Mild OSA or negative HSAT or PSG within past year with AHI 0-14
- Has refused oral appliances, CPAP, weight loss, surgery or positional therapy.
- Owns an iPhone 4 or newer and is comfortable downloading and using apps.
- Complaint of habitual snoring 3 or more nights per week
- Rated by polysomnograph technologist as moderate or loud snoring.
Exclusion Criteria:
- Non-fluent in English.
- Persistent rhinitis diagnosis or nasal obstruction.
- BMI > 32
- Greater than 5% variance in weight since sleep study.
- Diagnosis of moderate to severe sleep apnea or any other sleep disorder (insomnia, RLS)
- Insufficient sleep, defined as getting fewer than 6 hours of sleep on an average night based on self report.
- Spouse/partner is also a habitual snorer.
- Lacking ability to consent for themselves.
- Heavy drinker (self reported average more than 2 drinks per day).
- Regular narcotics (greater than 3 times/week)
- Epworth sleepiness scale score > 11 or one near miss accident in the past 6 months.
- Medical conditions as follows: symptomatic cardiopulmonary disease, chronic renal insufficiency, poorly controlled mental illness.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
|
Voice controlled smart phone game play 15 minutes daily and recording sounds of sleep environment 2 night per week for 12 weeks
|
Active Comparator: Control
|
Recording of sleep environment 2 nights per week for 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Snoring Intensity
Time Frame: 12 weeks
|
Snoring sounds >60 db
|
12 weeks
|
Snoring Rate
Time Frame: 12 weeks
|
Snoring sounds/hour of sleep
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep Quality
Time Frame: 12 weeks
|
Self reported sleep quality on likert scale (0 to 5)
|
12 weeks
|
Bed Partner Sleep Quality
Time Frame: 12 weeks
|
Bed partner reported sleep quality on likert scale (0 to 5)
|
12 weeks
|
Sleepiness
Time Frame: 12 weeks
|
Epworth sleepiness score
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2016
Primary Completion (Actual)
April 15, 2017
Study Completion (Actual)
May 18, 2017
Study Registration Dates
First Submitted
August 23, 2017
First Submitted That Met QC Criteria
August 24, 2017
First Posted (Actual)
August 29, 2017
Study Record Updates
Last Update Posted (Actual)
November 8, 2017
Last Update Submitted That Met QC Criteria
November 6, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1606S88671
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Snoring
-
Merz Pharmaceuticals GmbHTerminatedHabitual SnoringGermany
-
Johns Hopkins UniversityWithdrawn
-
Washington University School of MedicineRecruiting
-
Norton HealthcareDelta Dental FoundationRecruiting
-
VMS Medical Products, IncTerminated
-
Zelegent, Inc.CompletedSnoringUnited States
-
Brigham and Women's HospitalCompleted
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted